Additional studies are needed to determine whether patients with GBS with neurofascin IgM are at higher risk of progressing to CIDP or whether IgM antibodies contribute to pathogenesis. Here, CD40LG is linked to chronic inflammatory demyelinating polyradiculoneuropathy.